Cargando…

Cancer treatment during COVID-19 pandemic

Currently world is fighting with global pandemic of coronavirus disease 2019 (COVID-19). At this time of uncertainty, oncologists are struggling to provide appropriate care to cancer patients. They have to weigh risk and benefit of giving cancer treatment vs chances of getting them infected with COV...

Descripción completa

Detalles Bibliográficos
Autores principales: Jindal, Vishal, Sahu, Kamal Kant, Gaikazian, Susanna, Siddiqui, Ahmad Daniyal, Jaiyesimi, Ishmael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256336/
https://www.ncbi.nlm.nih.gov/pubmed/32472216
http://dx.doi.org/10.1007/s12032-020-01382-w
_version_ 1783539888386211840
author Jindal, Vishal
Sahu, Kamal Kant
Gaikazian, Susanna
Siddiqui, Ahmad Daniyal
Jaiyesimi, Ishmael
author_facet Jindal, Vishal
Sahu, Kamal Kant
Gaikazian, Susanna
Siddiqui, Ahmad Daniyal
Jaiyesimi, Ishmael
author_sort Jindal, Vishal
collection PubMed
description Currently world is fighting with global pandemic of coronavirus disease 2019 (COVID-19). At this time of uncertainty, oncologists are struggling to provide appropriate care to cancer patients. They have to weigh risk and benefit of giving cancer treatment vs chances of getting them infected with COVID-19. As cancer patients are immunocompromised and there are high chances of exposure during hospital visits and if they get infected, outcome can be fatal. So through the column of this article, we would like to provide basic guideline in management of cancer patients during COVID-19 pandemic.
format Online
Article
Text
id pubmed-7256336
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-72563362020-05-29 Cancer treatment during COVID-19 pandemic Jindal, Vishal Sahu, Kamal Kant Gaikazian, Susanna Siddiqui, Ahmad Daniyal Jaiyesimi, Ishmael Med Oncol Short Communication Currently world is fighting with global pandemic of coronavirus disease 2019 (COVID-19). At this time of uncertainty, oncologists are struggling to provide appropriate care to cancer patients. They have to weigh risk and benefit of giving cancer treatment vs chances of getting them infected with COVID-19. As cancer patients are immunocompromised and there are high chances of exposure during hospital visits and if they get infected, outcome can be fatal. So through the column of this article, we would like to provide basic guideline in management of cancer patients during COVID-19 pandemic. Springer US 2020-05-29 2020 /pmc/articles/PMC7256336/ /pubmed/32472216 http://dx.doi.org/10.1007/s12032-020-01382-w Text en © Springer Science+Business Media, LLC, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Short Communication
Jindal, Vishal
Sahu, Kamal Kant
Gaikazian, Susanna
Siddiqui, Ahmad Daniyal
Jaiyesimi, Ishmael
Cancer treatment during COVID-19 pandemic
title Cancer treatment during COVID-19 pandemic
title_full Cancer treatment during COVID-19 pandemic
title_fullStr Cancer treatment during COVID-19 pandemic
title_full_unstemmed Cancer treatment during COVID-19 pandemic
title_short Cancer treatment during COVID-19 pandemic
title_sort cancer treatment during covid-19 pandemic
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256336/
https://www.ncbi.nlm.nih.gov/pubmed/32472216
http://dx.doi.org/10.1007/s12032-020-01382-w
work_keys_str_mv AT jindalvishal cancertreatmentduringcovid19pandemic
AT sahukamalkant cancertreatmentduringcovid19pandemic
AT gaikaziansusanna cancertreatmentduringcovid19pandemic
AT siddiquiahmaddaniyal cancertreatmentduringcovid19pandemic
AT jaiyesimiishmael cancertreatmentduringcovid19pandemic